PROCEPT BioRobotics (PRCT) Net Equity Issued and Repurchased (2021 - 2024)

PROCEPT BioRobotics (PRCT) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $164.5 million in Q4 2024.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $164.5 million in Q4 2024; TTM through Dec 2024 was $163.2 million, a 12763.62% increase from a year earlier, with the FY2024 full-year figure at $164.5 million, up 1.74% from the prior year.
• Net Equity Issued and Repurchased for Q4 2024 stood at $164.5 million, up from -$1.3 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for PRCT reached as high as $164.5 million in Q4 2024 and fell as low as -$1.3 million in Q3 2022.
• Historically, Net Equity Issued and Repurchased has averaged $82.7 million across 3 years, with a median of $85.0 million in 2021.